Literature DB >> 9020184

Mitogen-activated protein kinase phosphatases inactivate stress-activated protein kinase pathways in vivo.

D D Hirsch1, P J Stork.   

Abstract

The c-Jun N-terminal protein kinases (JNKs), also called stress-activated protein kinases, are members of the growing family of serine/threonine kinases in the mitogen-activated protein (MAP) kinase superfamily. Like other MAP kinases, JNKs are activated via phosphorylation on adjacent threonine and tyrosine residues and can be inactivated by a unique family of dual specificity phosphatases, called MAP kinase phosphatases (MKPs). MKPs are encoded by immediate early genes and induced in response to environmental stressors and growth factor stimulation. Two prevalent isoforms of MKP, MKP1 and MKP2, are co-expressed in a wide variety of cell types. In this study, we examined the actions of MKP1 and MKP2 on JNK1 and JNK2. JNK1 phosphorylation and activation was inhibited by expression of both MKP1 and MKP2, although MKP1 selectivity toward JNK1 appeared significantly higher than that of MKP2. In contrast, JNK2 activity was inhibited by either phosphatase to similar degrees. Both MKP1 and MKP2 were highly effective at blocking the activation of the physiological target of JNK activation, the transcription factor c-Jun. In PC12 cells, MKP1 and MKP2 are transcriptionally induced following stimulation by nerve growth factor. In these cells, UV light-evoked JNK activation was reduced by pretreatment with nerve growth factor. Therefore, JNKs may be selective targets of MKP action in certain cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9020184     DOI: 10.1074/jbc.272.7.4568

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Suppression of Ras-induced apoptosis by the Rac GTPase.

Authors:  T Joneson; D Bar-Sagi
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Sequential activation of ERK and repression of JNK by scatter factor/hepatocyte growth factor in madin-darby canine kidney epithelial cells.

Authors:  R Paumelle; D Tulasne; C Leroy; J Coll; B Vandenbunder; V Fafeur
Journal:  Mol Biol Cell       Date:  2000-11       Impact factor: 4.138

3.  Diffusion control of protein phosphorylation in signal transduction pathways.

Authors:  B N Kholodenko; G C Brown; J B Hoek
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

Review 4.  Role of MAP kinase in neurons.

Authors:  K Fukunaga; E Miyamoto
Journal:  Mol Neurobiol       Date:  1998-02       Impact factor: 5.590

5.  Fluoxetine signature on hippocampal MAPK signalling in sex-dependent manner.

Authors:  Milos Mitic; Iva Lukic; Natalija Bozovic; Jelena Djordjevic; Miroslav Adzic
Journal:  J Mol Neurosci       Date:  2014-05-21       Impact factor: 3.444

6.  Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells.

Authors:  S Reffas; W Schlegel
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

7.  Heat-shock-induced activation of stress MAP kinase is regulated by threonine- and tyrosine-specific phosphatases.

Authors:  A N Nguyen; K Shiozaki
Journal:  Genes Dev       Date:  1999-07-01       Impact factor: 11.361

8.  Mitogen-activated protein kinase and neural specification in Xenopus.

Authors:  A R Uzgare; J A Uzman; H M El-Hodiri; A K Sater
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

9.  Activation of the ERK and JNK signaling pathways caused by neuron-specific inhibition of PP2A in transgenic mice.

Authors:  Stefan Kins; Pascal Kurosinski; Roger M Nitsch; Jürgen Götz
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

10.  Sampling-dependent up-regulation of gene expression in sequential samples of human airway epithelial cells.

Authors:  Adriana Heguy; Ben-Gary Harvey; Timothy P O'Connor; Neil R Hackett; Ronald G Crystal
Journal:  Mol Med       Date:  2003 Sep-Dec       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.